TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
IDT Australia Limited ( (AU:IDT) ) has shared an update.
IDT Australia Limited has announced the issuance of 634,304 fully paid ordinary shares to employees as a short-term incentive under the company’s LR 7.1 Placement Capacity. These shares, issued for nil consideration, are subject to a three-year on-sale restriction, reflecting the company’s strategy to incentivize and retain its workforce while potentially enhancing its market position.
More about IDT Australia Limited
IDT Australia Limited operates in the pharmaceutical industry, focusing on the development and manufacturing of pharmaceutical products. The company is known for its capabilities in drug formulation and production, catering primarily to the healthcare sector.
Average Trading Volume: 214,669
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$28.47M
For a thorough assessment of IDT stock, go to TipRanks’ Stock Analysis page.